--- title: "Gilead Sciences: Metrics Guide" description: "Gilead Sciences revenue, margins, cash flow and balance sheet figures by fiscal year, taken from its SEC filings, with the ratios computed and explained." canonical: https://www.getswoopr.com/stocks/companies/gilead-sciences/metrics/ source: "Swoopr Investment: https://www.getswoopr.com" --- ## Direct Answer > This guide identifies the key financial and operating metrics for Gilead Sciences (GILD), a biopharmaceutical company focused on HIV, oncology, and liver disease, explaining what each metric measures and how it connects to Gilead's revenue durability, pipeline productivity, and cash-generation capacity. # Gilead Sciences Financial Metrics & KPI Guide ## What Are Gilead Sciences's Key Financial Figures? | Fiscal year | FY2025ended December 31, 2025 | FY2024ended December 31, 2024 | FY2023ended December 31, 2023 | FY2022ended December 31, 2022 | | --- | --- | --- | --- | --- | | Revenue | $29.4 billion | $28.8 billion | $27.1 billion | $27.3 billion | | Operating income | $10.0 billion | $1.7 billion | $7.6 billion | $7.3 billion | | Operating margin | 34.0% | 5.8% | 28.0% | 26.9% | | Net income | $8.5 billion | $480 million | $5.7 billion | $4.6 billion | | Net margin | 28.9% | 1.7% | 20.9% | 16.8% | | Operating cash flow | $10.0 billion | $10.8 billion | $8.0 billion | $9.1 billion | | Capital expenditures | $563 million | $523 million | $585 million | $728 million | | Free cash flow | $9.5 billion | $10.3 billion | $7.4 billion | $8.3 billion | Operating margin widened by 28.3 percentage points between fiscal 2024 and 2025, which separates pricing and cost discipline from revenue growth alone. Free cash flow (operating cash flow minus capital expenditures) was $9.5 billion against net income of $8.5 billion; cash generation covered reported earnings. ![Bar chart of Gilead Sciences revenue, operating income, net income for fiscal 2022 to 2025. In fiscal 2025, revenue was $29.4 billion, operating income $10.0 billion and net income $8.5 billion.](https://www.getswoopr.com/images/charts/gilead-sciences-metrics-revenue-profit.webp) *Gilead Sciences revenue, operating income and net income by fiscal year, from the figures in the table above. Select the chart to open it full size.* ![Line chart of Gilead Sciences operating margin and net margin for fiscal 2022 to 2025. In fiscal 2025, operating margin was 34.0% and net margin was 28.9%.](https://www.getswoopr.com/images/charts/gilead-sciences-metrics-margins.webp) *Gilead Sciences operating margin and net margin by fiscal year: operating income and net income as a share of revenue. Select the chart to open it full size.* ![Bar chart of Gilead Sciences operating cash flow, capital expenditures, free cash flow for fiscal 2022 to 2025. In fiscal 2025, operating cash flow was $10.0 billion, capital expenditures was $563 million, free cash flow was $9.5 billion.](https://www.getswoopr.com/images/charts/gilead-sciences-metrics-cash-flow.webp) *Gilead Sciences operating cash flow, capital expenditures and free cash flow by fiscal year. Select the chart to open it full size.* ## What Does Gilead Sciences's Balance Sheet Show? | Cash and cash equivalents | $7.6 billion | | --- | --- | | Long-term debt | $22.1 billion | | Total assets | $59.0 billion | | Total liabilities | Not reported | | Shareholders' equity | $22.7 billion | | Current ratio | 1.6x | Balance sheet values are as of the end of fiscal 2025. Income statement figures describe a whole year; balance sheet figures describe a single day, so the two answer different questions. ## Where These Numbers Come From Every figure on this page is a value Gilead Sciences reported in its own SEC filings, read from the SEC's XBRL data (accession 0000882095-26-000006 for fiscal year 2025). Ratios are computed from those reported values. Figures were retrieved on October 7, 2026; a later amendment or a new annual report can change them, and the filing itself always takes precedence over this summary. Each fiscal year is labeled by the calendar year in which it ended, so a company that names the same period differently in its own filings (many retailers whose year ends in January) may use another label. A year is left out of the table when the SEC data set holds no value for it. A figure shown as "Not reported" means the company did not file a value under the standard tag Swoopr reads, not that the amount was zero. This page is educational and describes reported history only; it is not a forecast or a recommendation. ## Frequently Asked Questions ### What was Gilead Sciences's revenue in fiscal 2025? Gilead Sciences reported revenue of $29.4 billion for the fiscal year ended December 31, 2025, according to its SEC filings. ### What is Gilead Sciences's operating margin? Gilead Sciences's operating margin was 34.0% in fiscal 2025: operating income of $10.0 billion on revenue of $29.4 billion. ### How much free cash flow did Gilead Sciences generate? Operating cash flow of $10.0 billion less capital expenditures of $563 million gives free cash flow of $9.5 billion for fiscal 2025. ## References - [SEC EDGAR: GILEAD SCIENCES, INC. Form 10-K filed February 24, 2026](https://www.sec.gov/Archives/edgar/data/882095/000088209526000006/gild-20251231.htm) - [SEC EDGAR: GILEAD SCIENCES, INC. annual and quarterly filings](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=882095&type=10-K) - [SEC: EDGAR application programming interfaces (XBRL frames and submissions data)](https://www.sec.gov/search-filings/edgar-application-programming-interfaces) ## Related Pages - [Gilead Sciences company dossier](https://www.getswoopr.com/stocks/companies/gilead-sciences/) - [Gilead Sciences financial metrics](https://www.getswoopr.com/stocks/companies/gilead-sciences/metrics/) - [Gilead Sciences financial risk indicators](https://www.getswoopr.com/stocks/companies/gilead-sciences/risks/) - [Gilead Sciences peer comparison](https://www.getswoopr.com/stocks/companies/gilead-sciences/competitors/) - [Gilead Sciences business model and revenue mix](https://www.getswoopr.com/stocks/companies/gilead-sciences/business-model/) - [Fundamental analysis guides](https://www.getswoopr.com/learn/fundamental-analysis/) **[Swoopr Editorial Team](https://www.getswoopr.com/authors/swoopr-editorial-team/)** Swoopr's editorial team produces independent investment education content reviewed for accuracy and clarity. We do not provide personalized financial advice. See our [editorial policy](https://www.getswoopr.com/legal/editorial-policy/) and [corrections policy](https://www.getswoopr.com/legal/corrections-policy/).